

浏览全部资源
扫码关注微信
1.广西中医药大学,广西壮族自治区南宁市青秀区五合大道13号,530200
2.广西中医药大学第一附属医院
Received:12 April 2023,
Revised:2023-06-02,
Published:17 September 2023
移动端阅览
居燕飞,陈雅璐,蒙健林等.大黄灵仙方对胆道炎症模型大鼠胆管组织miRNA-30b表达及炎症-纤维化相关因子的影响[J].中医杂志,2023,64(18):1908-1915.
JU Yanfei,CHEN Yalu,MENG Jianlin,et al.Effect of Dahuang Lingxian Formula(大黄灵仙方)on miRNA-30b Expression and Inflammation-fibrosis Related Factors in Biliary Duct Tissue of Cholecystitis Model Rats[J].Journal of Traditional Chinese Medicine,2023,64(18):1908-1915.
居燕飞,陈雅璐,蒙健林等.大黄灵仙方对胆道炎症模型大鼠胆管组织miRNA-30b表达及炎症-纤维化相关因子的影响[J].中医杂志,2023,64(18):1908-1915. DOI: 10.13288/j.11-2166/r.2023.18.014.
JU Yanfei,CHEN Yalu,MENG Jianlin,et al.Effect of Dahuang Lingxian Formula(大黄灵仙方)on miRNA-30b Expression and Inflammation-fibrosis Related Factors in Biliary Duct Tissue of Cholecystitis Model Rats[J].Journal of Traditional Chinese Medicine,2023,64(18):1908-1915. DOI: 10.13288/j.11-2166/r.2023.18.014.
目的
2
探讨大黄灵仙方减轻胆道炎症防治胆石症的可能作用机制。
方法
2
将50只SD大鼠随机分为空白组、模型组、大黄灵仙组、大黄灵仙+空白抑制剂组、大黄灵仙+抑制剂组,每组10只。除空白组外,其余各组均采用脂多糖(LPS)诱导构建大鼠胆道炎症动物模型。大黄灵仙组、大黄灵仙+空白抑制剂组、大黄灵仙+抑制剂组三组大鼠制备胆道炎症模型前3天开始中药灌胃,给药剂量为320 mg/(kg·d),空白组、模型组大鼠给予2 ml/100 g蒸馏水灌胃,每天2次,连续干预6天。采用HE染色观察各组胆管病理形态改变,免疫组化法检测胆管核因子κB(NF-κB)蛋白表达,ELISA法检测大鼠血清白细胞介素1β(IL-1β)和肿瘤坏死因子α(TNF-α)表达水平,实时PCR法检测胆管组织中微小核糖核酸-30b(miRNA-30b)及转化生长因子β1(TGF-β1)、核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)和骨形态发生蛋白2(BMP2)mRNA表达,Western blot法检测TGF-β1、NLRP3以及BMP2蛋白表达量。
结果
2
与空白组比较,模型组大鼠胆管结构异常,汇管区内可见大量淋巴细胞、浆细胞浸润以及胆小管扩张,NF-κB蛋白阳性表达增加,出现核浸润,血清炎症因子IL-1β、TNF-α表达明显升高,胆管组织中TGF-β1、NLRP3、BMP2 mRNA以及蛋白表达量显著增加,miRNA-30b表达水平明显下降(
P
<0.01)。与模型组比较,大黄灵仙组和大黄灵仙+空白抑制剂组胆管病理形态均改善,炎性细胞浸润减少,NF-κB阳性表达降低,同时核浸润减轻,血清炎症因子IL-1β、TNF-α表达水平下降,胆管组织中TGF-β1、NLRP3、BMP2 mRNA以及蛋白表达量均降低,miRNA-30b表达水平均明显升高(
P
<0.05或
P
<0.01),而大黄灵仙+抑制剂组各指标改善不明显(
P
>0.05)。大黄灵仙组和大黄灵仙+空白抑制剂组各指标差异亦无统计学意义(
P
>0.05)。
结论
2
大黄灵仙方可能通过调控miRNA-30b及炎症-纤维化相关因子表达,起到延缓胆石症病程进展的作用。
Objective
2
To explore the possible mechanism of reducing cholecystitis and preventing cholelithiasis by
Dahuang Lingxian Formula
(大黄灵仙方, DLF).
Methods
2
Fifty SD rats were randomly divided into blank group, model group, DLF group, DLF + blank inhibitor group, and DLF + inhibitor group, with 10 rats in each group. The rat model of
c
holecystitis was established by lipopolysaccharide (LPS) induction in all the groups except for the blank group. Rats in DLF group, DLF + blank inhibitor group and DLF + inhibitor group received intragastric administration of 320 mg/ (kg·d) of DLF 3 days before the preparation of
c
holecystitis model, while those in blank group and model group were given 2 ml/100 g of distilled water by gastric, twice a day, for 6 consecutive days. Hematoxylin-eosin (HE) staining was used to observe the histopathologic changes of bile duct tissues in each group. The expression of nuclear factor κB (NF-κB) protein in bile duct tissues was detected by immunohistochemistry. The expression levels of interleukin1β (IL-1β) and tumor necrosis factor α (TNF-α) in serum of rats were detected by enzym-linked immunosorbent assay (ELISA). The mRNA expression levels of miRNA-30b, transforming growth factor β1 (TGF-β1), nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) and bone morphogenetic protein 2 (BMP2) in bile duct tissues were detected by real-time PCR, and the protein expression levels of TGF-β1, NLRP3 and BMP2 were detected by Western blot.
Results
2
Compared to those in the blank group, the structure of the bile duct in the model group was abnormal, and a large number of lymphocytes, plasma cell infiltration and bile canaliculi dilation were seen in the portal area; the positive expression of NF-κB protein increased; there was nuclear infiltration; the expressions of serum inflammatory factors IL-1β and TNF-α, as well as the mRNA and protein expressions of TGF-β1, NLRP3 and BMP2 in bile duct tissue significantly increased, while the expression level of miRNA-30b significantly decreased (
P
<0.01). Compared to those in the model group, the pathological morphology of the bile ducts in the DLF group and DLF + blank inhibitor group was improved, and the infiltration of inflammatory cells was reduced, with decreased positive expression of NF-κB and nuclear infiltration; expression levels of serum inflammatory factors IL-1β and TNF-α, and the mRNA and protein expressions of TGF-β1, NLRP3 and BMP2 in bile duct tissue decreased, while the expression level of miRNA-30b significantly increased (
P
<0.05 or
P
<0.01). Compared to the model group, those indicators in the DLF + inhibitor group was not significantly improved (
P
>0.05). There was no significant difference in the indicators between the DLF group and the DLF + blank inhibitor group (
P
>0.05).
Conclusion
2
DLF
may play a role in delaying the progression of cholelithiasis by regulating the expression of miRNA-30b and inflammation-fibrosis related factors.
GUTT C , SCHLAFER S , LAMMERT F . The treatment of gallstone disease [J]. Dtsch Arztebl Int , 2020 , 117 ( 9 ): 148 - 158 .
中国中西医结合学会消化系统疾病专业委员会 . 胆石症中西医结合诊疗共识意见(2017年) [J]. 中国中西医结合消化杂志 , 2018 , 26 ( 2 ): 132 - 138 .
MATYJAS T , KACZKA K , WITAS H , et al . Cholelithiasis-always infected? [J]. Pol Przegl Chir , 2017 , 89 ( 3 ): 23 - 26 .
ZHANG H , WANG D , TONG J , et al . MiR-30b-5p attenuates the inflammatory response and facilitates the functional recovery of spinal cord injury by targeting the NEFL/mTOR pathway [J]. Brain Behav , 2022 , 12 ( 12 ): e2788 .
LIU W , HAN X , LI Q , et al . Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation [J]. Biomed Pharmacother , 2022 , 153 : 113460 . doi: 10.1016/j.biopha.2022.113460 http://dx.doi.org/10.1016/j.biopha.2022.113460 .
WANG B , LIU T , WU JC , et al . STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration [J]. Biomed Pharmacother , 2018 , 98 : 214 - 221 . doi: 10.1016/j.biopha.2017.12.035 http://dx.doi.org/10.1016/j.biopha.2017.12.035 .
唐乾利 , 黄名威 , 俞渊 , 等 . “胆病从肝论治”在防治胆结石实验研究中的应用 [J]. 中医药信息 , 2010 , 27 ( 1 ): 16 - 19 .
唐乾利 , 刘祖军 , 伍松合 , 等 . 大黄灵仙胶囊降低胆石症术后残石率及复发率疗效观察 [J]. 新中医 , 2002 , 34 ( 6 ): 17 - 19 .
李泉 , 俞渊 , 黄欣 , 等 . 大黄灵仙胶囊预防保胆取石术后结石复发的基础与临床研究 [J]. 右江民族医学院学报 , 2014 , 36 ( 2 ): 161 - 164 .
周薇 , 唐乾利 , 赫军 , 等 . “大黄灵仙汤”治疗胆石症29例临床观察 [J]. 江苏中医药 , 2008 , 40 ( 6 ): 44 - 45 .
王清坚 , 王明刚 , 王兵 , 等 . 基于miRNA芯片技术探索大黄灵仙胶囊对炎性胆管细胞的多维调控 [J]. 广州中医药大学学报 , 2018 , 35 ( 2 ): 289 - 296 .
赵礼金 . LPS诱导胆管上皮细胞上皮—间叶样表型转化及其分子机制初步探讨 [D]. 重庆 : 第三军医大学 , 2010 .
吴华帅 , 俞渊 , 陈金梅 , 等 . 基于TLR4/MyD88信号通路探讨大黄灵仙方缓解胆管细胞炎症反应的作用研究 [J]. 中医药学报 , 2020 , 48 ( 5 ): 9 - 13 .
黄汉基 , 唐乾利 . “胆病从肝论治”理论探析与运用创新 [J]. 世界最新医学信息文摘 , 2019 , 19 ( 93 ): 268 - 269 .
臧西国 , 李轩 , 陈希琦 . 胆总管结石中西医治疗的研究进展 [J]. 中国疗养医学 , 2022 , 31 ( 8 ): 841 - 845 .
VESTERHUS M , KARLSEN TH . Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities [J]. J Gastroenterol , 2020 , 55 ( 6 ): 588 - 614 .
WANG Y , LIU Y , ZHANG L , et al . miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1 [J]. Biochem Biophys Res Commun , 2021 , 535 : 12 - 18 . doi: 10. 1016/j.bbrc.2020.10.096 http://dx.doi.org/10.1016/j.bbrc.2020.10.096 .
LIU ZY , CAO J , ZHANG JT , et al . Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- beta1-SMAD3-ID1 signaling pathway [J]. Oncotarget , 2017 , 8 ( 30 ): 49897 - 49914 .
KANG MH , KANG HN , KIM JL , et al . Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion [J]. Oncol Rep , 2009 , 22 ( 3 ): 525 - 534 .
COLUCCI S , ALTAMURA S , MARQUES O , et al . Liver sinusoidal endothelial cells suppress bone morphogenetic protein 2 production in response to TGFβ pathway activation [J]. Hepatology , 2021 , 74 ( 4 ): 2186 - 2200 .
ZHANG H , WANG Z . Effect and regulation of the NLRP3 inflammasome during renal fibrosis [J]. Front Cell Dev Biol , 2019 , 7 : 379 . doi: 10.3389/fcell. 2019. 00379 http://dx.doi.org/10.3389/fcell.2019.00379 .
ARTLETT CM . The Mechanism and regulation of the NLRP3 inflammasome during fibrosis [J]. Biomolecules , 2022 , 12 ( 5 ): 634 .
0
Views
9
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010102007558号